Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Curzen

Showing results (21-30 of 55) with videos related to

Pageof 6
Sort By:
International Journal of Cardiology|December 3, 2005
The limitations of coronary angiography: identification of a critical coronary stenosis using intravascular ultrasoundR A Swallow, I A Court, A L Calver, et al.
The Annals of Pharmacotherapy|September 6, 2007
Long-term continuation on cardiovascular drug treatment in patients with coronary heart diseaseDavid S Wald, Geraint Morton, Kate Walker, et al.
European Heart Journal|March 13, 2012
Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor?Lokpal S Bhatia, Nicholas P Curzen, Philip C Calder, et al.
European Journal of Heart Failure|April 6, 2013
Late gadolinium enhancement cardiac magnetic resonance imaging for the prediction of ventricular tachyarrhythmic events: a meta-analysisPaul A Scott, James A Rosengarten, Nick P Curzen, et al.
American Journal of Respiratory and Critical Care Medicine|August 1, 1997
In vivo treatment with endotoxin increases rat pulmonary vascular contractility despite NOS inductionM J Griffiths, N P Curzen, J A Mitchell, et al.
Platelets|September 16, 2006
Thromboelastography: potential bedside tool to assess the effects of antiplatelet therapy?R A Swallow, R A Agarwala, K D Dawkins, et al.
British Journal of Pharmacology|April 1, 1997
Evidence for a dilator function of 8-iso prostaglandin F2 alpha in rat pulmonary arteryK B Jourdan, T W Evans, N P Curzen, et al.
Heart (British Cardiac Society)|October 20, 2010
Dual antiplatelet therapy in cardiovascular disease: does aspirin increase clinical risk in the presence of potent P2Y12 receptor antagonists?Timothy D Warner, Paul C J Armstrong, Nicholas P Curzen, et al.
The International Journal of Cardiovascular Imaging|November 9, 2004
A reverse perfusion pattern during Technetium-99m stress myocardial perfusion imaging does not predict flow limiting coronary artery diseaseE J Smith, A Hussain, M Manoharan, et al.
Thrombosis Journal|March 4, 2008
Point-of-care platelet function assays demonstrate reduced responsiveness to clopidogrel, but not aspirin, in patients with Drug-Eluting Stent Thrombosis whilst on dual antiplatelet therapyAlex R Hobson, Graham Petley, Geraint Morton, et al.
Pageof 6

Showing results (21-30 of 55) with videos related to

Sort By:
Pageof 6
International Journal of Cardiology|December 3, 2005
The limitations of coronary angiography: identification of a critical coronary stenosis using intravascular ultrasoundR A Swallow, I A Court, A L Calver, et al.
The Annals of Pharmacotherapy|September 6, 2007
Long-term continuation on cardiovascular drug treatment in patients with coronary heart diseaseDavid S Wald, Geraint Morton, Kate Walker, et al.
European Heart Journal|March 13, 2012
Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor?Lokpal S Bhatia, Nicholas P Curzen, Philip C Calder, et al.
European Journal of Heart Failure|April 6, 2013
Late gadolinium enhancement cardiac magnetic resonance imaging for the prediction of ventricular tachyarrhythmic events: a meta-analysisPaul A Scott, James A Rosengarten, Nick P Curzen, et al.
American Journal of Respiratory and Critical Care Medicine|August 1, 1997
In vivo treatment with endotoxin increases rat pulmonary vascular contractility despite NOS inductionM J Griffiths, N P Curzen, J A Mitchell, et al.
Platelets|September 16, 2006
Thromboelastography: potential bedside tool to assess the effects of antiplatelet therapy?R A Swallow, R A Agarwala, K D Dawkins, et al.
British Journal of Pharmacology|April 1, 1997
Evidence for a dilator function of 8-iso prostaglandin F2 alpha in rat pulmonary arteryK B Jourdan, T W Evans, N P Curzen, et al.
Heart (British Cardiac Society)|October 20, 2010
Dual antiplatelet therapy in cardiovascular disease: does aspirin increase clinical risk in the presence of potent P2Y12 receptor antagonists?Timothy D Warner, Paul C J Armstrong, Nicholas P Curzen, et al.
The International Journal of Cardiovascular Imaging|November 9, 2004
A reverse perfusion pattern during Technetium-99m stress myocardial perfusion imaging does not predict flow limiting coronary artery diseaseE J Smith, A Hussain, M Manoharan, et al.
Thrombosis Journal|March 4, 2008
Point-of-care platelet function assays demonstrate reduced responsiveness to clopidogrel, but not aspirin, in patients with Drug-Eluting Stent Thrombosis whilst on dual antiplatelet therapyAlex R Hobson, Graham Petley, Geraint Morton, et al.
Pageof 6